FTC sues to block Amgen acquisition of Horizon Therapeutics

📆 16/05/2023 20:02:00
📰 CNBC

⏱ Reading Time:
21 sec. here
2 min. at publisher
📊 Quality Score:
News: 12%
Publisher: 72%

Italia Notizia Notizia

Italia Ultime Notizie,Italia Notizie

The deal was a bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.

Sources familiar with the matter told CNBC's David Faber earlier Tuesday that Amgen is prepared to defend the acquisition, with one source adding the company expects to "win big."

Representatives for Amgen and for Horizon Therapeutics did not immediately respond to a request for comment from CNBC.The two drugmakers said in February that the FTC sent themThousand Oaks, California-based Amgen to buy Horizon Therapeutics in early December and said it expected to complete the sale in the first half of this year.for key treatments over the next decade.CNBC Health & Science

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

Scrivi un Commento

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

Robocall company behind 'billions' of illegal calls sued by FTCXCast Labs, a company accused of helping make billions of illegal robocalls, was sued on Friday by the U.S. Federal Trade Commission, which asked the court to order the company to stop the practice.
Fonte: Reuters - 🏆 2. / 97 Leggi di più »